XML 26 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating Activities    
Net income $ 329,176 $ 62,734
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 217,762 331,117
Equity in net income from unconsolidated joint ventures (9,709) (14,104)
Distributions of cumulative earnings from unconsolidated joint ventures 10,174 19,609
Equity in net gain on sale of interest in unconsolidated joint venture interest/real estate (136,522) (16,166)
Purchase price and other fair value adjustments (57,385) 0
Depreciable real estate reserves 6,691 85,336
(Gain) loss on sale of real estate, net (6,227) 3,256
Loan loss reserves and other investment reserves, net of recoveries 1,087 0
Gain on sale of investments in marketable securities 0 (3,262)
Loss on early extinguishment of debt 2,194 0
Deferred rents receivable (11,328) (33,523)
Other non-cash adjustments 8,907 21,224
Changes in operating assets and liabilities:    
Tenant and other receivables 3,186 (2,318)
Related party receivables 5,186 (8,238)
Deferred lease costs (31,828) (31,479)
Other assets (52,172) (58,068)
Accounts payable, accrued expenses, other liabilities and security deposits 20,715 773
Deferred revenue and land leases payable 17,638 55,361
Net cash provided by operating activities 317,545 412,252
Investing Activities    
Acquisitions of real estate property (40,279) (25,114)
Additions to land, buildings and improvements (163,750) (251,906)
Investments in unconsolidated joint ventures (298,836) (112,697)
Distributions in excess of cumulative earnings from unconsolidated joint ventures 208,724 279,478
Net proceeds from disposition of real estate/joint venture interest 892,350 160,649
Proceeds from sale or redemption of marketable securities 0 55,129
Other investments 991 46,955
Origination of debt and preferred equity investments (652,309) (935,724)
Repayments or redemption of debt and preferred equity investments 553,341 707,676
Net cash provided by (used in) investing activities 500,232 (75,554)
Financing Activities    
Proceeds from mortgages and other loans payable 339,125 779,650
Repayments of mortgages and other loans payable (351,080) (706,056)
Proceeds from revolving credit facility and senior unsecured notes 2,205,000 1,447,800
Repayments of revolving credit facility and senior unsecured notes (2,000,000) (1,270,804)
Proceeds from stock options exercised and DRIP issuance 15,689 12,475
Repurchase of common stock (760,073) (349,991)
Redemption of preferred stock (350) (125)
Distributions to noncontrolling interests in other partnerships (1,863) (45,089)
Contributions from noncontrolling interests in other partnerships 4,900 33,202
Distributions to noncontrolling interests in the Operating Partnership (11,469) (10,639)
Dividends / Distributions paid on common and preferred stock / units (237,007) (251,701)
Other obligations related to loan participations (3,842) 16,737
Tax withholdings related to restricted share awards 16 (3,879)
Deferred loan costs and capitalized lease obligation (8,257) (8,993)
Net cash used in financing activities (809,211) (357,413)
Net increase (decrease) in cash, cash equivalents, and restricted cash 8,566 (20,715)
Cash, cash equivalents, and restricted cash at end of period 258,592 349,252
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Issuance of units in the Operating Partnership 0 23,273
Conversion of units in the Operating Partnership for common stock 1,560 15,352
Tenant improvements and capital expenditures payable 16,246 8,926
Fair value adjustment to noncontrolling interest in Operating Partnership 7,448 2,669
Deconsolidation of subsidiaries 298,391 328,643
Transfer of assets related to assets held for sale 734,008 273,455
Transfer of liabilities related to assets held for sale 310,496 1,290
Removal of fully depreciated commercial real estate properties 115,320 11,158
Share repurchase payable 41,746 0
Total cash, cash equivalents, and restricted cash 258,592 349,252
SL Green Operating Partnership    
Operating Activities    
Net income 329,176 62,734
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 217,762 331,117
Equity in net income from unconsolidated joint ventures (9,709) (14,104)
Distributions of cumulative earnings from unconsolidated joint ventures 10,174 19,609
Equity in net gain on sale of interest in unconsolidated joint venture interest/real estate (136,522) (16,166)
Purchase price and other fair value adjustments (57,385) 0
Depreciable real estate reserves 6,691 85,336
(Gain) loss on sale of real estate, net (6,227) 3,256
Loan loss reserves and other investment reserves, net of recoveries 1,087 0
Gain on sale of investments in marketable securities 0 (3,262)
Loss on early extinguishment of debt 2,194 0
Deferred rents receivable (11,328) (33,523)
Other non-cash adjustments 8,907 21,224
Changes in operating assets and liabilities:    
Tenant and other receivables 3,186 (2,318)
Related party receivables 5,186 (8,238)
Deferred lease costs (31,828) (31,479)
Other assets (52,172) (58,068)
Accounts payable, accrued expenses, other liabilities and security deposits 20,715 773
Deferred revenue and land leases payable 17,638 55,361
Net cash provided by operating activities 317,545 412,252
Investing Activities    
Acquisitions of real estate property (40,279) (25,114)
Additions to land, buildings and improvements (163,750) (251,906)
Investments in unconsolidated joint ventures (298,836) (112,697)
Distributions in excess of cumulative earnings from unconsolidated joint ventures 208,724 279,478
Net proceeds from disposition of real estate/joint venture interest 892,350 160,649
Proceeds from sale or redemption of marketable securities 0 55,129
Other investments 991 46,955
Origination of debt and preferred equity investments (652,309) (935,724)
Repayments or redemption of debt and preferred equity investments 553,341 707,676
Net cash provided by (used in) investing activities 500,232 (75,554)
Financing Activities    
Proceeds from mortgages and other loans payable 339,125 779,650
Repayments of mortgages and other loans payable (351,080) (706,056)
Proceeds from revolving credit facility and senior unsecured notes 2,205,000 1,447,800
Repayments of revolving credit facility and senior unsecured notes (2,000,000) (1,270,804)
Proceeds from stock options exercised and DRIP issuance 15,689 12,475
Repurchase of common stock (760,073) (349,991)
Redemption of preferred stock (350) (125)
Distributions to noncontrolling interests in other partnerships (1,863) (45,089)
Contributions from noncontrolling interests in other partnerships 4,900 33,202
Dividends / Distributions paid on common and preferred stock / units (248,476) (262,340)
Other obligations related to loan participations (3,842) 16,737
Tax withholdings related to restricted share awards 16 (3,879)
Deferred loan costs and capitalized lease obligation (8,257) (8,993)
Net cash used in financing activities (809,211) (357,413)
Net increase (decrease) in cash, cash equivalents, and restricted cash 8,566 (20,715)
Cash, cash equivalents, and restricted cash at beginning of year 250,026 369,967
Cash, cash equivalents, and restricted cash at end of period 258,592 349,252
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Issuance of units in the Operating Partnership 0 23,273
Conversion of units in the Operating Partnership for common stock 1,560 15,352
Redemption of units in the Operating Partnership for the sale of a joint venture 10,445 0
Tenant improvements and capital expenditures payable 16,246 8,926
Fair value adjustment to noncontrolling interest in Operating Partnership 7,448 2,669
Deconsolidation of subsidiaries 298,391 328,643
Transfer of assets related to assets held for sale 734,008 273,455
Transfer of liabilities related to assets held for sale 310,496 1,290
Removal of fully depreciated commercial real estate properties 115,320 11,158
Total cash, cash equivalents, and restricted cash $ 250,026 $ 369,967